Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Human Genome Sciences receives milestone for GSK-716155 IND filing

Jan. 16, 2006

LSN-2120310's activity against a wide range of menopausal symptoms

Jan. 13, 2006

Recent patents report new therapeutic agents for diabetes and other endocrine-related disorders

Jan. 13, 2006

Hemopure to be submitted for European approval in mid-2006

Jan. 13, 2006

Phase I study for PV-903 for treatment of recurrent miscarriages

Jan. 13, 2006

Novel SARMs subject of Merck & Co. patent

Jan. 12, 2006

Alkermes and Lilly sign agreement for inhaled PTH development

Jan. 12, 2006

FDA approves quarterly intravenous Boniva for postmenopausal osteoporosis

Jan. 11, 2006

Lilly ruled to have breached oral PTH license agreements with Emisphere

Jan. 11, 2006

Zonagen receives IRB approval to begin phase III study of Androxal

Jan. 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...